Alexsandra Mowday

10PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsWastewater treatment processesTumour immunologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 01, 2024
Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery.

Jan Theys, Adam V Patterson, Alexandra M Mowday

|Nov 17, 2023
Design and Biological Evaluation of Piperazine-Bearing Nitrobenzamide Hypoxia/GDEPT Prodrugs: The Discovery of CP-506.

Amir Ashoorzadeh, Alexandra M Mowday, Maria R Abbattista

|Feb 26, 2022
Interrogation of the Structure-Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications.

Amir Ashoorzadeh, Alexandra M Mowday, Christopher P Guise

|Dec 28, 2021
Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3.

Maria R Abbattista, Amir Ashoorzadeh, Christopher P Guise

|Oct 09, 2021
Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506.

Alexander M A van der Wiel, Victoria Jackson-Patel, Raymon Niemans

Pageof 2